Follow
Luis Gerardo Rodríguez-Lobato
Luis Gerardo Rodríguez-Lobato
Hospital Clínic of Barcelona
Verified email at clinic.cat
Title
Cited by
Cited by
Year
CAR T-cells in multiple myeloma: state of the art and future directions
LG Rodríguez-Lobato, M Ganzetti, C Fernandez de Larrea, M Hudecek, ...
Frontiers in Oncology 10, 1243, 2020
752020
Evolving M-protein pattern in patients with smoldering multiple myeloma: impact on early progression
C Fernandez de Larrea, I Isola, A Pereira, MT Cibeira, L Magnano, ...
Leukemia 32 (6), 1427-1434, 2018
632018
Gut microbiota influence in hematological malignancies: from genesis to cure
M Uribe-Herranz, N Klein-González, LG Rodríguez-Lobato, M Juan, ...
International Journal of Molecular Sciences 22 (3), 1026, 2021
392021
Nectin-2 expression on malignant plasma cells is associated with better response to TIGIT blockade in multiple myeloma
E Lozano, MP Mena, T Díaz, B Martin-Antonio, S León, ...
Clinical Cancer Research 26 (17), 4688-4698, 2020
372020
European Myeloma Network perspective on CAR T-Cell therapies for multiple myeloma
B Bruno, R Wäsch, M Engelhardt, F Gay, L Giaccone, M D’Agostino, ...
Haematologica 106 (8), 2054, 2021
312021
Impact of severe acute kidney injury and chronic kidney disease on allogeneic hematopoietic cell transplant recipients: a retrospective single center analysis
G Gutiérrez-García, J Villarreal, M Garrote, M Rovira, M Blasco, ...
Bone marrow transplantation 55 (7), 1264-1271, 2020
232020
Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation
G Gutiérrez-García, M Rovira, L Magnano, L Rosiñol, A Bataller, ...
Bone Marrow Transplantation 53 (12), 1541-1547, 2018
232018
Loss of the immune checkpoint CD85j/LILRB1 on malignant plasma cells contributes to immune escape in multiple myeloma
E Lozano, T Díaz, MP Mena, G Suñe, X Calvo, M Calderón, L Pérez-Amill, ...
The Journal of Immunology 200 (8), 2581-2591, 2018
222018
Bone marrow plasma cell infiltration in light chain amyloidosis: impact on organ involvement and outcome
N Tovar, LG Rodríguez-Lobato, MT Cibeira, L Magnano, I Isola, L Rosiñol, ...
Amyloid 25 (2), 79-85, 2018
222018
Complement as the enabler of carfilzomib‐induced thrombotic microangiopathy
M Blasco, A Martínez‐Roca, LG Rodríguez‐Lobato, A Garcia‐Herrera, ...
British Journal of Haematology 193 (1), 181-187, 2021
192021
First report of CART treatment in AL amyloidosis and relapsed/refractory multiple myeloma
A Oliver-Caldes, R Jiménez, M Español-Rego, MT Cibeira, ...
Journal for Immunotherapy of Cancer 9 (12), 2021
192021
A reproducible and safe at-home allogeneic haematopoietic cell transplant program: first experience in Central and Southern Europe
G Gutiérrez-García, M Rovira, N Arab, C Gallego, J Sánchez, ...
Bone Marrow Transplantation 55 (5), 965-973, 2020
192020
Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA …
A Oliver-Caldés, V González-Calle, V Cabañas, M Español-Rego, ...
The Lancet Oncology 24 (8), 913-924, 2023
172023
Factors associated with the clinical outcome of patients with relapsed/refractory CD19+ acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy
V Ortiz-Maldonado, S Rives, M Español-Rego, A Alonso-Saladrigues, ...
Journal for immunotherapy of cancer 9 (12), 2021
152021
Tumor necrosis factor alpha and interleukin 10 promoter polymorphisms in Mexican patients with restenosis after coronary stenting
MA Martínez-Ríos, MA Peña-Duque, JM Fragoso, H Delgadillo-Rodríguez, ...
Biochemical genetics 47, 707-716, 2009
142009
Risk factors for mortality in hematopoietic stem cell transplantation recipients with bloodstream infection: points to be addressed by future guidelines
P Puerta-Alcalde, M Chumbita, P Charry, S Castaño-Díez, C Cardozo, ...
Transplantation and Cellular Therapy 27 (6), 501. e1-501. e6, 2021
122021
Homocysteine is related to aortic mineralization in patients with ischemic heart disease
MA Peña-Duque, MA Baños-González, B Valente-Acosta, ...
Journal of Atherosclerosis and Thrombosis 19 (3), 292-297, 2012
122012
Why immunotherapy fails in multiple myeloma
LG Rodríguez-Lobato, A Oliver-Caldés, DF Moreno, ...
Hemato 2 (1), 1-42, 2020
102020
Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
AI Pérez-Valencia, E Cascos, S Carbonell-Ordeig, P Charry, ...
Blood Advances 7 (10), 2018-2031, 2023
92023
All-trans retinoic acid works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T cells
E García-Guerrero, LG Rodríguez-Lobato, B Sierro-Martínez, S Danhof, ...
Haematologica 108 (2), 568, 2023
92023
The system can't perform the operation now. Try again later.
Articles 1–20